232 related articles for article (PubMed ID: 24465224)
21. Generalized connective tissue disease in Crtap-/- mouse.
Baldridge D; Lennington J; Weis M; Homan EP; Jiang MM; Munivez E; Keene DR; Hogue WR; Pyott S; Byers PH; Krakow D; Cohn DH; Eyre DR; Lee B; Morello R
PLoS One; 2010 May; 5(5):e10560. PubMed ID: 20485499
[TBL] [Abstract][Full Text] [Related]
22. Lack of cyclophilin B in osteogenesis imperfecta with normal collagen folding.
Barnes AM; Carter EM; Cabral WA; Weis M; Chang W; Makareeva E; Leikin S; Rotimi CN; Eyre DR; Raggio CL; Marini JC
N Engl J Med; 2010 Feb; 362(6):521-8. PubMed ID: 20089953
[TBL] [Abstract][Full Text] [Related]
23. [Mutations of noncollagen genes in osteogenesis imperfecta--implications of the gene products in collagen biosynthesis and pathogenesis of disease].
Galicka A
Postepy Hig Med Dosw (Online); 2012 Jun; 66():359-71. PubMed ID: 22706122
[TBL] [Abstract][Full Text] [Related]
24. Substitution of murine type I collagen A1 3-hydroxylation site alters matrix structure but does not recapitulate osteogenesis imperfecta bone dysplasia.
Cabral WA; Fratzl-Zelman N; Weis M; Perosky JE; Alimasa A; Harris R; Kang H; Makareeva E; Barnes AM; Roschger P; Leikin S; Klaushofer K; Forlino A; Backlund PS; Eyre DR; Kozloff KM; Marini JC
Matrix Biol; 2020 Aug; 90():20-39. PubMed ID: 32112888
[TBL] [Abstract][Full Text] [Related]
25. Mutations in FKBP10 cause recessive osteogenesis imperfecta and Bruck syndrome.
Kelley BP; Malfait F; Bonafe L; Baldridge D; Homan E; Symoens S; Willaert A; Elcioglu N; Van Maldergem L; Verellen-Dumoulin C; Gillerot Y; Napierala D; Krakow D; Beighton P; Superti-Furga A; De Paepe A; Lee B
J Bone Miner Res; 2011 Mar; 26(3):666-72. PubMed ID: 20839288
[TBL] [Abstract][Full Text] [Related]
26. Collagen prolyl 3-hydroxylation: a major role for a minor post-translational modification?
Hudson DM; Eyre DR
Connect Tissue Res; 2013; 54(4-5):245-51. PubMed ID: 23772978
[TBL] [Abstract][Full Text] [Related]
27. CRTAP is required for prolyl 3- hydroxylation and mutations cause recessive osteogenesis imperfecta.
Morello R; Bertin TK; Chen Y; Hicks J; Tonachini L; Monticone M; Castagnola P; Rauch F; Glorieux FH; Vranka J; Bächinger HP; Pace JM; Schwarze U; Byers PH; Weis M; Fernandes RJ; Eyre DR; Yao Z; Boyce BF; Lee B
Cell; 2006 Oct; 127(2):291-304. PubMed ID: 17055431
[TBL] [Abstract][Full Text] [Related]
28. Characterization of recombinant human prolyl 3-hydroxylase isoenzyme 2, an enzyme modifying the basement membrane collagen IV.
Tiainen P; Pasanen A; Sormunen R; Myllyharju J
J Biol Chem; 2008 Jul; 283(28):19432-9. PubMed ID: 18487197
[TBL] [Abstract][Full Text] [Related]
29. Prolyl 3-hydroxylase 1 null mice display abnormalities in fibrillar collagen-rich tissues such as tendons, skin, and bones.
Vranka JA; Pokidysheva E; Hayashi L; Zientek K; Mizuno K; Ishikawa Y; Maddox K; Tufa S; Keene DR; Klein R; Bächinger HP
J Biol Chem; 2010 May; 285(22):17253-62. PubMed ID: 20363744
[TBL] [Abstract][Full Text] [Related]
30. An additional function of the rough endoplasmic reticulum protein complex prolyl 3-hydroxylase 1·cartilage-associated protein·cyclophilin B: the CXXXC motif reveals disulfide isomerase activity in vitro.
Ishikawa Y; Bächinger HP
J Biol Chem; 2013 Nov; 288(44):31437-46. PubMed ID: 24043621
[TBL] [Abstract][Full Text] [Related]
31. Biochemical characterization of the prolyl 3-hydroxylase 1.cartilage-associated protein.cyclophilin B complex.
Ishikawa Y; Wirz J; Vranka JA; Nagata K; Bächinger HP
J Biol Chem; 2009 Jun; 284(26):17641-7. PubMed ID: 19419969
[TBL] [Abstract][Full Text] [Related]
32. Genetic Analysis, Phenotypic Spectrum and Functional Study of Rare Osteogenesis Imperfecta Caused by CRTAP Variants.
Zhou B; Gao P; Hu J; Lin X; Sun L; Zhang Q; Jiang Y; Wang O; Xia W; Xing X; Li M
J Clin Endocrinol Metab; 2024 Jun; 109(7):1803-1813. PubMed ID: 38214665
[TBL] [Abstract][Full Text] [Related]
33. [Genetic basis for skeletal disease. Osteogenesis imperfecta and genetic abnormalities].
Hasegawa K
Clin Calcium; 2010 Aug; 20(8):1190-5. PubMed ID: 20675929
[TBL] [Abstract][Full Text] [Related]
34. The identification of novel mutations in COL1A1, COL1A2, and LEPRE1 genes in Chinese patients with osteogenesis imperfecta.
Zhang ZL; Zhang H; Ke YH; Yue H; Xiao WJ; Yu JB; Gu JM; Hu WW; Wang C; He JW; Fu WZ
J Bone Miner Metab; 2012 Jan; 30(1):69-77. PubMed ID: 21667357
[TBL] [Abstract][Full Text] [Related]
35. Homozygosity for a missense mutation in SERPINH1, which encodes the collagen chaperone protein HSP47, results in severe recessive osteogenesis imperfecta.
Christiansen HE; Schwarze U; Pyott SM; AlSwaid A; Al Balwi M; Alrasheed S; Pepin MG; Weis MA; Eyre DR; Byers PH
Am J Hum Genet; 2010 Mar; 86(3):389-98. PubMed ID: 20188343
[TBL] [Abstract][Full Text] [Related]
36. New genes in bone development: what's new in osteogenesis imperfecta.
Marini JC; Blissett AR
J Clin Endocrinol Metab; 2013 Aug; 98(8):3095-103. PubMed ID: 23771926
[TBL] [Abstract][Full Text] [Related]
37. Cell differentiation and matrix organization are differentially affected during bone formation in osteogenesis imperfecta zebrafish models with different genetic defects impacting collagen type I structure.
Daponte V; Tonelli F; Masiero C; Syx D; Exbrayat-Héritier C; Biggiogera M; Willaert A; Rossi A; Coucke PJ; Ruggiero F; Forlino A
Matrix Biol; 2023 Aug; 121():105-126. PubMed ID: 37336269
[TBL] [Abstract][Full Text] [Related]
38. Cellular stress due to impairment of collagen prolyl hydroxylation complex is rescued by the chaperone 4-phenylbutyrate.
Besio R; Garibaldi N; Leoni L; Cipolla L; Sabbioneda S; Biggiogera M; Mottes M; Aglan M; Otaify GA; Temtamy SA; Rossi A; Forlino A
Dis Model Mech; 2019 Jun; 12(6):. PubMed ID: 31171565
[TBL] [Abstract][Full Text] [Related]
39. CRTAP mutations in lethal and severe osteogenesis imperfecta: the importance of combining biochemical and molecular genetic analysis.
Van Dijk FS; Nesbitt IM; Nikkels PG; Dalton A; Bongers EM; van de Kamp JM; Hilhorst-Hofstee Y; Den Hollander NS; Lachmeijer AM; Marcelis CL; Tan-Sindhunata GM; van Rijn RR; Meijers-Heijboer H; Cobben JM; Pals G
Eur J Hum Genet; 2009 Dec; 17(12):1560-9. PubMed ID: 19550437
[TBL] [Abstract][Full Text] [Related]
40. Sclerostin Antibody Treatment Improves the Bone Phenotype of Crtap(-/-) Mice, a Model of Recessive Osteogenesis Imperfecta.
Grafe I; Alexander S; Yang T; Lietman C; Homan EP; Munivez E; Chen Y; Jiang MM; Bertin T; Dawson B; Asuncion F; Ke HZ; Ominsky MS; Lee B
J Bone Miner Res; 2016 May; 31(5):1030-40. PubMed ID: 26716893
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
